• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于帕金森病体外建模的人源中脑类器官的可重复生成

Reproducible generation of human midbrain organoids for in vitro modeling of Parkinson's disease.

作者信息

Nickels Sarah Louise, Modamio Jennifer, Mendes-Pinheiro Bárbara, Monzel Anna Sophia, Betsou Fay, Schwamborn Jens Christian

机构信息

Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, L-4367 Belvaux, Luxembourg; Integrated Biobank of Luxembourg (IBBL), Luxembourg Institute of Health, L-3555 Dudelange, Luxembourg.

Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, L-4367 Belvaux, Luxembourg.

出版信息

Stem Cell Res. 2020 Jul;46:101870. doi: 10.1016/j.scr.2020.101870. Epub 2020 Jun 6.

DOI:10.1016/j.scr.2020.101870
PMID:32534166
Abstract

The study of human midbrain development and midbrain related diseases, like Parkinson's disease (PD), is limited by deficiencies in the currently available and validated laboratory models. Three dimensional midbrain organoids represent an innovative strategy to recapitulate some aspects of the complexity and physiology of the human midbrain. Nevertheless, also these novel organoid models exhibit some inherent weaknesses, including the presence of a necrotic core and batch-to-batch variability. Here we describe an optimized approach for the standardized generation of midbrain organoids that addresses these limitations, while maintaining key features of midbrain development like dopaminergic neuron and astrocyte differentiation. Moreover, we have established a novel time-efficient, fit for purpose analysis pipeline and provided proof of concept for its usage by investigating toxin induced PD.

摘要

人类中脑发育及与中脑相关疾病(如帕金森病,PD)的研究受到当前可用且经过验证的实验室模型缺陷的限制。三维中脑类器官是一种创新策略,可概括人类中脑复杂性和生理学的某些方面。然而,这些新型类器官模型也存在一些固有弱点,包括坏死核心的存在和批次间的变异性。在此,我们描述了一种优化方法,用于标准化生成中脑类器官,该方法解决了这些局限性,同时保留了中脑发育的关键特征,如多巴胺能神经元和星形胶质细胞分化。此外,我们建立了一种新型的省时、适用的分析流程,并通过研究毒素诱导的帕金森病为其应用提供了概念验证。

相似文献

1
Reproducible generation of human midbrain organoids for in vitro modeling of Parkinson's disease.用于帕金森病体外建模的人源中脑类器官的可重复生成
Stem Cell Res. 2020 Jul;46:101870. doi: 10.1016/j.scr.2020.101870. Epub 2020 Jun 6.
2
Neural stem cells derived from human midbrain organoids as a stable source for treating Parkinson's disease: Midbrain organoid-NSCs (Og-NSC) as a stable source for PD treatment.源自人脑中脑组织类器官的神经干细胞作为治疗帕金森病的稳定来源:中脑组织类器官-神经干细胞(Og-NSC)作为 PD 治疗的稳定来源。
Prog Neurobiol. 2021 Sep;204:102086. doi: 10.1016/j.pneurobio.2021.102086. Epub 2021 May 28.
3
Derivation of Human Midbrain-Specific Organoids from Neuroepithelial Stem Cells.人脑神经上皮干细胞来源的中脑组织类器官的建立。
Stem Cell Reports. 2017 May 9;8(5):1144-1154. doi: 10.1016/j.stemcr.2017.03.010. Epub 2017 Apr 13.
4
Generation of Human Ventral Midbrain Organoids Derived from Pluripotent Stem Cells.人胚中脑神经节器官原代细胞的培养。
Curr Protoc. 2022 Sep;2(9):e555. doi: 10.1002/cpz1.555.
5
From 2D to 3D: Development of Monolayer Dopaminergic Neuronal and Midbrain Organoid Cultures for Parkinson's Disease Modeling and Regenerative Therapy.从 2D 到 3D:用于帕金森病建模和再生治疗的单层多巴胺能神经元和中脑组织类器官培养的发展。
Int J Mol Sci. 2023 Jan 28;24(3):2523. doi: 10.3390/ijms24032523.
6
Use of 3D Organoids as a Model to Study Idiopathic Form of Parkinson's Disease.使用 3D 类器官作为研究特发性帕金森病模型。
Int J Mol Sci. 2020 Jan 21;21(3):694. doi: 10.3390/ijms21030694.
7
Machine learning-assisted neurotoxicity prediction in human midbrain organoids.机器学习辅助人类中脑组织器官的神经毒性预测。
Parkinsonism Relat Disord. 2020 Jun;75:105-109. doi: 10.1016/j.parkreldis.2020.05.011. Epub 2020 May 8.
8
Modeling Parkinson's disease in midbrain-like organoids.在类中脑器官中模拟帕金森病。
NPJ Parkinsons Dis. 2019 Apr 5;5:5. doi: 10.1038/s41531-019-0078-4. eCollection 2019.
9
Single-cell transcriptomics identifies perturbed molecular pathways in midbrain organoids using α-synuclein triplication Parkinson's disease patient-derived iPSCs.单细胞转录组学使用α-突触核蛋白三倍体帕金森病患者来源 iPSCs 鉴定中脑类器官中失调的分子途径。
Neurosci Res. 2023 Oct;195:13-28. doi: 10.1016/j.neures.2023.06.001. Epub 2023 Jun 3.
10
Modeling G2019S-LRRK2 Sporadic Parkinson's Disease in 3D Midbrain Organoids.在 3D 中脑类器官中建立 G2019S-LRRK2 散发性帕金森病模型。
Stem Cell Reports. 2019 Mar 5;12(3):518-531. doi: 10.1016/j.stemcr.2019.01.020. Epub 2019 Feb 21.

引用本文的文献

1
Distinct microRNA signatures define sporadic PSP-RS and PD in patient-derived midbrain organoids.独特的微小RNA特征在源自患者的中脑类器官中区分散发性进行性核上性麻痹和帕金森病。
iScience. 2025 Jul 18;28(8):113162. doi: 10.1016/j.isci.2025.113162. eCollection 2025 Aug 15.
2
Update on the Present and Future Pharmacologic Treatment of Parkinson's Disease.帕金森病当前及未来药物治疗的最新进展
Neurol Ther. 2025 Jul 18. doi: 10.1007/s40120-025-00800-3.
3
Current status and future prospects of toxicity assessment using organoids.使用类器官进行毒性评估的现状与未来展望。
Toxicol Res. 2025 Jun 13;41(4):325-333. doi: 10.1007/s43188-025-00298-9. eCollection 2025 Jul.
4
Induced Pluripotent (iPSC) and Mesenchymal (MSC) Stem Cells for In Vitro Disease Modeling and Regenerative Medicine.用于体外疾病建模和再生医学的诱导多能干细胞(iPSC)和间充质干细胞(MSC)
Int J Mol Sci. 2025 Jun 11;26(12):5617. doi: 10.3390/ijms26125617.
5
An Efficient Organoid Cutting Method for Long-Term Culture and High-Throughput Analyses.一种用于长期培养和高通量分析的高效类器官切割方法。
Tissue Eng Regen Med. 2025 Jun 16. doi: 10.1007/s13770-025-00731-y.
6
Necrosis as a fundamental driver of loss of resilience and biological decline: what if we could intervene?坏死作为恢复力丧失和生物衰退的根本驱动因素:如果我们能够干预会怎样?
Oncogene. 2025 May 29. doi: 10.1038/s41388-025-03431-y.
7
Mechanically and Chemically Defined PEG Hydrogels Improve Reproducibility in Human Cardioid Development.机械和化学定义的聚乙二醇水凝胶提高了人类心脏发育研究的可重复性。
Adv Healthc Mater. 2025 Jun;14(16):e2403997. doi: 10.1002/adhm.202403997. Epub 2025 May 16.
8
Deciphering shared molecular dysregulation across Parkinson's disease variants using a multi-modal network-based data integration and analysis.使用基于多模态网络的数据整合与分析来解读帕金森病不同变体之间共享的分子失调情况。
NPJ Parkinsons Dis. 2025 Mar 31;11(1):63. doi: 10.1038/s41531-025-00914-3.
9
Exploring organoid and assembloid technologies: a focus on retina and brain.探索类器官和组装体技术:聚焦于视网膜和大脑。
Expert Rev Mol Med. 2025 Mar 27;27:e14. doi: 10.1017/erm.2025.9.
10
Insulin resistance compromises midbrain organoid neuronal activity and metabolic efficiency predisposing to Parkinson's disease pathology.胰岛素抵抗损害中脑类器官神经元活动和代谢效率,易引发帕金森病病理改变。
J Tissue Eng. 2025 Jan 28;16:20417314241295928. doi: 10.1177/20417314241295928. eCollection 2025 Jan-Dec.